Our data suggested that melatonin is a potential therapeutic option for LSD1-overexpressing oral cancer, but the detailed action mechanism of melatonin in oral cancer requires further detailed investigation. This evidence concerns the gene KDM1A and lip and oral cavity carcinoma.